fdareview.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | FDA |
| Description | Username: Password: FDA-RELATED NEWS FDA-RELATED NEWS 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >> 2-Day Workshop on Generic Research Iniitiatives FDA anno |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.130.151.244 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
fdareview.com Valuation
|
US$251,560
Last updated: 2023-05-15 13:30:58
fdareview.com has Semrush global rank of 42,074,742. fdareview.com has an estimated worth of US$ 251,560, based on its estimated Ads revenue. fdareview.com receives approximately 29,027 unique visitors each day. Its web server is located in United States, with IP address 104.130.151.244. According to SiteAdvisor, fdareview.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$251,560 |
| Daily Ads Revenue | US$233 |
| Monthly Ads Revenue | US$6,967 |
| Yearly Ads Revenue | US$83,596 |
| Daily Unique Visitors | 1,936 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| fdareview.com. | A | 3600 | IP: 104.130.151.244 |
| fdareview.com. | NS | 7200 | NS Record: ns64.worldnic.com. |
| fdareview.com. | NS | 7200 | NS Record: ns63.worldnic.com. |
HtmlToTextCheckTime:2023-05-15 13:30:58
| Username: Password: FDA-RELATED NEWS FDA-RELATED NEWS 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >> 2-Day Workshop on Generic Research Iniitiatives FDA announces a 5/11-12 workshop entitled Fiscal Year 2023 Generic Drug Science and Research Initiatives Public Workshop. 05/08/2023 Orphan Status for Pyxis Pancreatic Cancer Therapy FDA grants Pyxis Oncology an orphan drug designation for PYX-201 in pancreatic cancer. 05/12/2023 Cordis Class 1 Recall of Angioguard System Rated Class 1 by FDA, Cordis recalls its Angioguard RX/XP Emboli Capture Guidewire System due to device separation concerns. 05/12/2023 Congress Urges More FDA Attention to Rare Diseases A bipartisan group of U.S. Senators and House members call on FDA to step up its regulatory activities to improve rare disease product development and reviews. 05/12/2023 FDA Encourages Voluntary Device Shortage Notices Due to its authority having expired on 5/11 with the end of the Covid-10 public health emergency (PHE), FDA now urges |
HTTP Headers
HTTP/1.1 200 OK Content-Length: 0 Content-Type: text/html Server: Microsoft-IIS/7.5 X-Powered-By: PHP/5.0.0 X-Powered-By: ASP.NET Date: Sat, 01 Jan 2022 09:01:28 GMT |
fdareview.com Whois Information
Domain Name: FDAREVIEW.COM Registry Domain ID: 428328_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-01-28T07:56:55Z Creation Date: 1997-03-28T05:00:00Z Registry Expiry Date: 2022-03-29T04:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS63.WORLDNIC.COM Name Server: NS64.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-02T07:50:11Z <<< |